Last reviewed · How we verify

NCT04790578

EXCEL: Technology and Exercise Adherence

Status unknown NA Last updated 7 April 2022
What this trial tests

NA trial testing ZoeInsights Application in Cancer in 140 participants. Status unknown.

Timeline
1 April 2021
Primary endpoint
30 December 2022
30 June 2023

Quick facts

Lead sponsorUniversity of Calgary
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment140
Start date1 April 2021
Primary completion30 December 2022
Estimated completion30 June 2023
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

University of Calgary

Who can join

19 and older, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Exercise adherence and maintenance in the EXCEL program supported with a smart phone application: A pilot randomized controlled trial

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effectiveness of a Self-Monitoring App in Supporting Physical Activity Maintenance Among Rural Canadians With Cancer After an Exercise Oncology Program: Cluster Randomized Controlled Trial.
    Ester M, Wagoner CW, Dreger J, Chen G, et al · · 2023 · cited 7× · PMID 37676714 · DOI 10.2196/47187

Verify or expand the search:

Other recruiting trials for Cancer

Currently open trials in the same condition.

Other University of Calgary trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04790578.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing